title: Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.
authors: Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
authors: P
authors: P
authors: Emery
authors: John Hopkins University, Baltimore, USA.
authors: C O
authors: CO
authors: Bingham
authors: Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
authors: G R
authors: GR
authors: Burmester
authors: Weill Cornell Medical College, Division of Rheumatology, Hospital for Special Surgery, New York, USA.
authors: V P
authors: VP
authors: Bykerk
authors: Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, USA.
authors: D E
authors: DE
authors: Furst
authors: Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM U1184, Le Kremlin Bicêtre, France.
authors: X
authors: X
authors: Mariette
authors: Leiden University Medical Centre, Leiden, The Netherlands.
authors: D van der
authors: Dv
authors: Heijde
authors: Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute, Stockholm, Sweden.
authors: R van
authors: Rv
authors: Vollenhoven
authors: UCB Pharma, Brussels, Belgium.
authors: C
authors: C
authors: Arendt
authors: UCB Pharma, Brussels, Belgium.
authors: I
authors: I
authors: Mountian
authors: UCB Pharma, Brussels, Belgium.
authors: O
authors: O
authors: Purcaru
authors: UCB Pharma, Raleigh, USA.
authors: D
authors: D
authors: Tatla
authors: UCB Pharma, Raleigh, USA.
authors: B
authors: B
authors: VanLunen
authors: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, USA.
authors: M E
authors: ME
authors: Weinblatt
mesh_terms: D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid; D006801:Humans
chemical_list: D018501:Antirheumatic Agents
keywords: DMARDs (biologic); Early Rheumatoid Arthritis; Methotrexate